Intervention

bone marrow ablation with stem cell support

ClinicalTrials.gov intervention label

Clinical trials6

Recruiting0

Common conditions8

Lead sponsors shown5

Clinical trials

6 shown

Combination Chemotherapy With or Without Trastuzumab Followed By an Autologous Stem Cell Transplant and Radiation Therapy in Treating Patients With Stage III or Stage IV Breast CancerNCT00182793 · 2005-07-01

Antiviral Therapy Plus Either Peripheral Stem Cell or Umbilical Cord Blood Transplantation in Treating Patients Who Are HIV Positive and Have Hematologic CancerNCT00003435 · 1998-05-01

High-Dose Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Metastatic Breast CancerNCT00003392 · 1997-09-01

Chemotherapy Followed by Peripheral Stem Cell or Bone Marrow Transplant Compared With Chemotherapy Alone in Treating Patients With Small Cell Lung CancerNCT00011921 · 1997-09-01

Chemotherapy and Stem Cell Transplantation in Treating Patients With Stage IIIB Breast CancerNCT00003042 · 1997-05-30

High-Dose Chemotherapy, Total-Body Irradiation, and Autologous Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Hematologic Cancer or Solid TumorsNCT00060255 · 1991-12-01

Common conditions

Breast Cancer4 Leukemia2 Lymphoma2 Lung Cancer1 Multiple Myeloma and Plasma Cell Neoplasm1 Testicular Germ Cell Tumor1 Unspecified Adult Solid Tumor, Protocol Specific1 Unspecified Childhood Solid Tumor, Protocol Specific1

Leading sponsors

City of Hope Medical Center2 Duke University1 EBMT Solid Tumors Working Party1 Roswell Park Cancer Institute1 UNC Lineberger Comprehensive Cancer Center1

Trial status mix

COMPLETED4

UNKNOWN1

WITHDRAWN1

Phase mix

PHASE24

PHASE11

PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.